Biontech and Moderna expand production – mRNA technology as a feature

Frankfurt Biontech / Pfizer vaccine manufacturers and modern Expand their delivery schedules. PfizerAt the G20 summit in Rome on Friday evening, its president, Albert Burla, announced that one billion doses would be delivered to low-income countries this year and next. Moderna wants to supply approximately 60 million cans this year and 900 million cans in 2022. The American Group Johnson & Johnson It only promised 500 million doses for both years. AstraZeneca He was not represented at the top.

Advertisements from Rome show that mRNA producers can expand their range without any problems. In a few weeks, mRNA vaccine manufacturers have increased their 2022 production plans from 5.5 billion to nearly eight billion doses.